fr-264205

Ceftolozane sulfate (FR-264205/CXA-101) is a cephalosporin antibiotic, a penicillin-binding protein (PBP) inhibitor with antipseudomonal activity, used for infection research including pneumonia.

Ceftolozane, also known as FR-264,205 and CXA-101; is an antibiotic drug from the cephalosporin family, approved for the treatment of infections with gram-negative bacteria, or gram-positive bacteria. Ceftolozane is of great benefit due to its ability to target bacteria that have become resistant to conventional antibiotics. Ceftolozane is combined with the β-lactamase inhibitor tazobactam, as multi-drug resistant bacterial infections will generally show resistance to all β-lactam antibiotics unless this enzyme is inhibited. .